Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Physostigmine salicylate for postoperative delirium after aortocoronary bypass surgery
ISRCTN33122761Phase 3Completed
- Sponsor
- Franz Köhler Chemie
- Start
- Dec 2008
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in delirium comparing Physostigmine salicylate with Placebo (2 arms). Started Dec 2008; status: completed.
02
Drugs
physostigmine
03
Conditions
delirium
Beyond the preview
Go deeper on ISRCTN33122761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN33122761.